Skip to main content
$16.53 -$0.18 (-1.1%)

01:00 PM EST on 11/26/21

EyePoint Pharmaceuticals (NASDAQ:EYPT)

CAPS Rating: No stars

Current Price $16.53 Mkt Cap $566.4M
Open $16.30 P/E Ratio 0.00
Prev. Close $16.53 Div. (Yield) $0.00 (0.0%)
Daily Range $16.21 - $17.24 Volume 331,820
52-Wk Range $4.00 - $21.50 Avg. Daily Vol. 980,013

Caps

How do you think NASDAQ:EYPT will perform against the market?

Add Stock to CAPS Watchlist

All Players

3 Outperform
1 Underperform
 

All-Star Players

1 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:EYPT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

SmartAce (98.86)
Submitted May 09, 2019

Remember when there was nothing to check and no device to check it on and all you did was live your life?

NASDAQ:EYPT VS S&P 500 (SPY)

NASDAQ:EYPT Summary

Fools bullish on NASDAQ:EYPT are also bullish on:

Fools bearish on NASDAQ:EYPT are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about EYPT.

No one has written a Pitch for EYPT stock yet. Tell us why you think EYPT will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in EYPT.

Score Leader

DarkExplorer

DarkExplorer (87.37) Score: +957.16

The Score Leader is the player with the highest score across all their picks in EYPT.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
DarkExplorer 87.37 12/13/2019 Outperform 3M $1.50 +1,002.00% +44.84% +957.16 0 Comment
TMFGBudwell 67.39 9/16/2019 Outperform 5Y $1.89 +774.60% +53.07% +721.53 0 Comment
cruisin25 53.37 11/16/2021 Outperform 3M $13.78 +19.92% -2.00% +21.93 0 Comment
onthewallst 28.16 3/10/2020 Underperform 5Y $1.02 +1,520.59% +63.65% -1,456.94 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for EYPT.